Ledger.Open graph →
SEC Form D · filed March 9, 2026

AirNexis Therapeutics, Inc

Offering
$200.0M
Sold
$62.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Anna Chen · Palo Alto, CADirectorColin Walsh · San Francisco, CADirectorEvan Caplan · Palo Alto, CADirectorJames Li · Palo Alto, CAExec · DirectorJill Carroll · BRISBANE, CADirectorMaria Fardis · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗